18 March 2020

GSK Stockmann contributed to the publication of The Legal 500 Country Comparative Guide – Luxembourg: Securitisation

The 1st edition of The Legal 500 Country Comparative Guide (Luxembourg) for Securitisation has been published by Legalease as part of a series of online country-specific legal guides in order to give insight to the law and regulations in unfamiliar jurisdictions. Each country chapter is written by a firm ranked by The Legal 500 in an easy to use Q&A format. 

The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of securitisation law across a variety of jurisdictions. The chapter provides information about the current issues affecting securitisation in a particular country and addresses topics such as regulations, SPVs and transfer of assets, as well as insight and opinion on the most common issues in Luxembourg.

GSK Stockmann contributed to the Guide’s publication: Andreas Heinzmann (lawyer and Partner at GSK Stockmann in Luxembourg), Valerio Scollo (lawyer and Senior Associate at GSK Stockmann in Luxembourg) and Dr Manuel Fernandez (lawyer and Senior Associate at GSK Stockmann in Luxembourg) composed the Luxembourg chapter Securitisation.

The whole guide is free to access on the website

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
Contact person

Andreas Heinzmann, LL.M. eur.

Partner

+352 271802-30

andreas.heinzmann@gsk-lux.com

Valerio Scollo, LL.M. (NYU), LL.M. (NUS)

Partner

+352 271802-32

valerio.scollo@gsk-lux.com

Dr. Manuel Fernandez

Partner

+352 271802-31

manuel.fernandez@gsk-lux.com

© GSK Stockmann 2024